{"id":"https://openalex.org/W2028083881","doi":"https://doi.org/10.1097/qai.0b013e31827171d7","title":"Drug-Resistant Virus Has Reduced Ability to Induce Immune Activation","display_name":"Drug-Resistant Virus Has Reduced Ability to Induce Immune Activation","publication_year":2012,"publication_date":"2012-12-01","ids":{"openalex":"https://openalex.org/W2028083881","doi":"https://doi.org/10.1097/qai.0b013e31827171d7","mag":"2028083881","pmid":"https://pubmed.ncbi.nlm.nih.gov/23138731"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0b013e31827171d7","doi":"https://doi.org/10.1097/qai.0b013e31827171d7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e31827171d7","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499025","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100431099","display_name":"Rui Wang","orcid":"https://orcid.org/0000-0001-5007-193X","observed_orcids":["https://orcid.org/0000-0001-5007-193X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rui Wang","raw_affiliation_strings":["Department of Biostatistics, Harvard School of Public Health, Boston, MA","Division of Sleep Medicine, Brigham and Women\u2019s Hospital, Boston, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Sleep Medicine, Brigham and Women\u2019s Hospital, Boston, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029030800","display_name":"Ronald J. Bosch","orcid":"https://orcid.org/0000-0002-1774-4140","observed_orcids":["https://orcid.org/0000-0002-1774-4140"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald J. Bosch","raw_affiliation_strings":["Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078117679","display_name":"Constance Ann Benson","orcid":"https://orcid.org/0000-0002-3781-1347","observed_orcids":["https://orcid.org/0000-0002-3781-1347"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constance A. Benson","raw_affiliation_strings":["Division of Infectious Diseases, School of Medicine, University of California, San Diego, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, School of Medicine, University of California, San Diego, San Diego, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072899489","display_name":"Michael M. Lederman","orcid":"https://orcid.org/0000-0001-9247-8025","observed_orcids":["https://orcid.org/0000-0001-9247-8025"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael M. Lederman","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5100431099"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":0.1317,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.49431595,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"61","issue":"4","first_page":"e60","last_page":"e63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-drug-resistance","display_name":"HIV-1 drug resistance","score":0.9129999876022339},{"id":"https://openalex.org/keywords/immune-activation","display_name":"immune activation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tnf-receptor-2","display_name":"TNF receptor 2","score":0.7540000081062317},{"id":"https://openalex.org/keywords/structured-treatment-interruption","display_name":"structured treatment interruption","score":0.6679999828338623},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.675000011920929},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.4429999887943268},{"id":"https://openalex.org/keywords/viral-rebound","display_name":"viral rebound","score":0.3959999978542328},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.5699999928474426},{"id":"https://openalex.org/keywords/cd8-t-cell-activation","display_name":"CD8+ T cell activation","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.6319849491119385},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5904803276062012},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5717224478721619},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5020685195922852},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3962160050868988},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37002241611480713},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34903115034103394},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21112599968910217}],"mesh":[{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006684","descriptor_name":"HLA-DR Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006684","descriptor_name":"HLA-DR Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006684","descriptor_name":"HLA-DR Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008562","descriptor_name":"Membrane Glycoproteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051997","descriptor_name":"ADP-ribosyl Cyclase 1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D051997","descriptor_name":"ADP-ribosyl Cyclase 1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D051997","descriptor_name":"ADP-ribosyl Cyclase 1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/qai.0b013e31827171d7","doi":"https://doi.org/10.1097/qai.0b013e31827171d7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e31827171d7","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:23138731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23138731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Letter"},{"id":"pmh:oai:europepmc.org:2830034","doi":null,"is_oa":false,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499025","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3499025","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499025","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Acquir Immune Defic Syndr","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3499025","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499025","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Acquir Immune Defic Syndr","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8799999952316284,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3672534956","display_name":null,"funder_award_id":"U01 AI038855","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G374818150","display_name":null,"funder_award_id":"U01AI068634","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4553935269","display_name":null,"funder_award_id":"UM1-AI-068636","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5456484914","display_name":"ADULT ACTG CENTRAL GROUP","funder_award_id":"U01AI038858","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G650174051","display_name":null,"funder_award_id":"U01AI068636","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G857487509","display_name":null,"funder_award_id":"UM1-AI068634","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000863735","display_name":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","funder_award_id":"5um1ai068636-19","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000886520","display_name":"Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)","funder_award_id":"5um1ai068634-19","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320315488","display_name":"ACT Government","ror":"https://ror.org/03fy7b149"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1965317332","https://openalex.org/W1971440513","https://openalex.org/W1978033187","https://openalex.org/W2002398367","https://openalex.org/W2015134483","https://openalex.org/W2019450345","https://openalex.org/W2065180342","https://openalex.org/W2072276094","https://openalex.org/W2087092404","https://openalex.org/W2105804574","https://openalex.org/W2106401051","https://openalex.org/W2138694347","https://openalex.org/W2153136696","https://openalex.org/W2166653928","https://openalex.org/W4232932066"],"related_works":["https://openalex.org/W2016551366","https://openalex.org/W2188759708","https://openalex.org/W2138564085","https://openalex.org/W2123163123","https://openalex.org/W292004825","https://openalex.org/W2147145791","https://openalex.org/W4386371748","https://openalex.org/W2111970140","https://openalex.org/W1874513932","https://openalex.org/W2094230406"],"abstract_inverted_index":{"To":[0,150],"the":[1,76,88,152,166,205,210,217,233,281,315,347,371,384,397,411,419,428,538,552,768,863,895,900,916,934,943,963,978,987,999,1012,1015,1028,1078,1087,1096,1140,1156,1170,1230,1257,1295,1349,1369,1391,1428,1437,1440,1472,1480,1486,1503,1507,1545,1563,1607,1654,1681,1706,1748,1783,1801,1808,1818],"Editors:":[2],"There":[3],"is":[4,87,1519,1646,1673],"increasing":[5],"suspicion":[6],"that":[7,39,75,100,154,441,962,1378,1397,1521,1651,1768,1786],"HIV-induced":[8],"immune":[9,162,387,405,558,588,1306,1330,1342,1386,1573,1608,1657,1667,1688,1724,1743],"activation":[10,109,185,236,309,559,1307,1331,1343,1396,1421,1574,1609,1640,1658,1668,1689,1744],"contributes":[11],"to":[12,160,209,232,263,272,294,331,526,549,582,685,772,921,983,1034,1083,1128,1136,1200,1345,1360,1384,1427,1436,1453,1485,1622,1653,1734,1794],"accelerated":[13],"cellular":[14,184],"turnover,":[15],"CD4+":[16,651,693,753,797,847],"T-cell":[17,94,108,127,130,308],"losses,":[18],"and":[19,22,66,132,171,183,191,195,279,307,312,345,391,404,459,471,498,502,512,544,568,624,669,698,713,793,850,857,881,905,1004,1103,1153,1198,1209,1226,1245,1274,1303,1319,1356,1419,1477,1570,1636,1662,1685,1705,1820,1823],"increased":[20,50,737,1746,1777],"morbidity":[21],"mortality":[23,58],"of":[24,42,52,64,90,141,175,204,216,235,252,317,349,353,370,377,413,421,554,587,852,865,873,884,936,945,965,980,1001,1014,1030,1080,1133,1155,1172,1232,1260,1329,1341,1351,1363,1394,1413,1439,1479,1488,1509,1547,1549,1565,1582,1606,1638,1644,1648,1656,1683,1687,1692,1700,1711,1742,1758,1803,1811],"HIV-infected":[25,1812],"individuals,":[26],"even":[27,1670],"for":[28,61,114,500,514,528,774,894,933,942,1024,1053,1253,1283,1313,1471,1727],"those":[29,1464,1478],"on":[30,189,383,396,437,481,557,627,638,650,672,692,724,796,820,832,968,1572,1586],"antiretroviral":[31,270,1696,1703],"treatment.1\u20134":[32],"For":[33],"example,":[34],"Kuller":[35,1762],"et":[36,71,97,120,1374,1409,1455,1577,1763],"al5":[37],"found":[38,1579],"higher":[40,62,1500,1769],"levels":[41,63,135,306,574,623,700,769,872,883,950,957,1056,1186,1244,1267,1286,1393,1771],"interleukin-6":[43],"(IL-6)":[44],"were":[45,59,227,261,329,517,524,535,718,951,1009,1066,1121,1125,1163,1187,1262,1398,1449,1512,1524,1690,1721,1774],"significantly":[46,757,953,1745],"associated":[47,954,1722,1775],"with":[48,57,84,103,143,255,325,578,585,689,721,808,871,882,918,955,1038,1069,1190,1204,1210,1265,1278,1309,1336,1348,1368,1390,1402,1446,1460,1463,1465,1492,1604,1723,1776,1782],"an":[49,123,1179],"risk":[51],"all-cause":[53],"mortality;":[54],"similar":[55,908,1047,1279,1555],"associations":[56],"seen":[60,1010,1108,1399,1552,1754],"d-dimer":[65],"high-sensitivity":[67],"C-Reactive":[68],"Protein.":[69],"Deeks":[70],"al6":[72],"have":[73,106,1715],"hypothesized":[74],"preserved":[77],"immunologic":[78],"function":[79],"in":[80,93,138,337,575,1299,1305,1315,1332,1372,1400,1432,1451,1490,1496,1502,1526,1544,1553,1602,1659,1663,1761,1807,1827],"many":[81,1664],"treated":[82,1334,1665],"patients":[83,102,254,1177,1445,1491,1693],"drug-resistant":[85,104,155,1337,1352,1379,1403],"viremia":[86,105,1489,1645,1672,1684],"result":[89],"a":[91,139,248,265,286,321,368,408,464,472,616,661,1414,1527,1536,1554,1629,1678],"reduction":[92],"activation.":[95],"Hunt":[96,1373,1408,1454,1481,1504],"al7":[98],"reported":[99,122],"antiretroviral-treated":[101],"lower":[107,1392],"than":[110,1124,1501,1515],"untreated":[111],"patients,":[112],"controlling":[113,941,1052,1282],"plasma":[115,304,340,529,571,734],"HIV-1":[116,133,334,392,530,563,572,621,735,897,948,974,1054,1184,1242,1284,1316,1364,1634,1660,1738],"RNA":[117,134,393,531,564,573,622,699,736,898,949,975,1055,1185,1243,1285,1317,1365,1635,1739],"level.":[118],"Kitchen":[119],"al8":[121],"oscillatory":[124],"relationship":[125,167,385,1679,1730],"between":[126,168,386,399,619,665,902,998,1099,1149,1241,1297,1416,1474,1596,1632,1680],"activation,":[128,163,388,1387,1725],"CD4":[129,190,666,681,716],"counts,":[131],"over":[136],"time":[137,322],"group":[140],"subjects":[142,207,226,260,372,1459,1819],"highly":[144],"resistant":[145,257],"HIV":[146,430,845],"infection":[147],"followed":[148,268],"longitudinally.":[149],"test":[151,935],"hypothesis":[153],"virus":[156,293,338,580,1380,1404],"has":[157,1381],"reduced":[158,1382],"ability":[159,1383],"induce":[161,1385],"we":[164,381,1235,1625],"analyzed":[165,536],"drug":[169,335,389,424,431,555,1300,1447,1461,1493,1550],"resistance":[170,240,327,336,416,425,432,556,981,1081,1101,1114,1126,1134,1151,1301,1417,1448,1462,1551],"both":[172],"soluble":[173,1339],"markers":[174,186,586,1158,1340],"inflammation":[176],"(IL-6,":[177],"tumor":[178],"necrosis":[179],"factor":[180],"[TNF]-\u03b1,":[181],"TNF-rII)":[182],"(CD38/HLA-DR":[187],"expression":[188,626,671,819,1637],"CD8":[192,725,1395,1420],"T-cells)":[193],"before":[194],"after":[196,285,738,940,986,1051,1086,1139,1281,1755],"short-term":[197,287],"treatment":[198,212,275,288,318,739,988,1016,1088,1141,1173,1233,1557,1750,1759,1787,1804],"interruption,":[199,1234,1751],"using":[200,418,519,537],"data":[201,241],"from":[202,229,339,356,427,1616],"16":[203],"21":[206],"randomized":[208,249,262],"structured":[211],"interruption":[213,289,319,740,989,1017,1089,1142,1558,1760,1788,1805],"(STI)":[214],"arm":[215],"Adult":[218],"Clinical":[219],"Trials":[220],"Group":[221],"(ACTG)":[222],"5086":[223,246,1829],"study.":[224,1505],"The":[225,244,259,333,542,1063,1112,1411,1642,1698,1815],"excluded":[228],"analysis":[230],"due":[231,1426],"unavailability":[234],"(4":[237],"subjects)":[238],"or":[239,647,829,1007,1071,1130,1161,1168,1248,1310,1435,1601,1613],"(1":[242],"subject).":[243],"ACTG":[245,1821,1828],"was":[247,299,341,547,560,868,907,970,1049,1105,1499,1753],"clinical":[250,1809],"trial":[251],"41":[253],"multi-drug":[256],"HIV.":[258],"undergo":[264],"16-week":[266],"STI":[267,350],"by":[269,1407,1542,1737],"treatment,":[271],"evaluate":[273],"if":[274,280],"responses":[276,1793],"are":[277,1618],"improved":[278],"new":[282,1537],"regimen":[283],"started":[284],"can":[290],"revert":[291],"circulating":[292],"wild":[295],"type9;":[296],"this":[297,1327,1357,1433,1497,1531,1712,1717,1729],"strategy":[298],"not":[300,706,719,952,971,1067,1219,1237,1321,1533,1591,1627,1694,1732,1790],"successful.":[301],"We":[302,461,611,659,1293,1560,1589],"measured":[303],"cytokine":[305],"at":[310,314,320,343,346,444,483,855,1011,1116,1166,1169,1182,1229,1354,1422,1516,1530,1535,1611],"baseline":[311,344,567,620,1117,1167,1423,1612,1617,1633],"then":[313],"end":[316,348,1013,1171,1231,1508],"when":[323,1614,1671],"viruses":[324],"fewer":[326],"mutations":[328,403,426,443,482,867,904,967,982,1003,1032,1065,1082,1115,1127,1135,1261,1302,1353,1418,1568,1585,1720],"expected":[330],"predominate.":[332],"obtained":[342],"(before":[351],"initiation":[352],"optimized":[354],"treatment)":[355],"standard":[357],"genotyping":[358],"(ViroSeq":[359],"version":[360],"2,":[361],"Celera":[362],"Diagnostics,":[363],"Alameda,":[364],"CA),":[365],"but":[366,704,805,915,1215],"only":[367,1444],"minority":[369],"had":[373],"nearly":[374],"complete":[375],"reemergence":[376],"drug-susceptible":[378],"HIV-1.9":[379],"Here,":[380],"focus":[382],"resistance,":[390,1494],"levels.":[394,532,565,976,1740],"Based":[395],"association":[398,1098],"protease":[400],"inhibitor":[401,468,476],"(PI)":[402],"activation,6we":[406],"defined":[407],"PI":[409,415,423,866,903,946,966,984,1002,1129,1584],"score,":[410],"number":[412,864,944,979,1000,1350],"major":[414,422,1583],"mutations,":[417,947,1599],"list":[420],"Stanford":[429],"database":[433],"(http://hivdb.stanford.edu/pages/documentPage/PI_mutationClassification.html,":[434],"last":[435],"updated":[436],"May":[438],"6,":[439],"2011),":[440],"is,":[442],"amino":[445,484],"acid":[446,485],"positions":[447,486],"30,":[448],"32,":[449],"46,":[450],"47,":[451],"48,":[452],"50,":[453],"54,":[454],"76,":[455],"82,":[456],"84,":[457],"88,":[458],"90.":[460],"also":[462,770,1388,1561,1766],"calculated":[463],"nucleoside":[465],"reverse":[466,474],"transcriptase":[467,475],"(NRTI)":[469],"score":[470,478,1102,1119,1152],"nonnucleoside":[473],"(NNRTI)":[477],"similarly":[479],"based":[480],"41,":[487],"65,":[488],"67,":[489],"69,":[490],"70,":[491],"74,":[492],"75,":[493],"115,":[494],"151,":[495],"184,":[496],"210,":[497],"215":[499],"NRTIs":[501],"100,":[503],"101,":[504],"103,":[505],"106,":[506],"179,":[507],"181,":[508],"188,":[509],"190,":[510],"230,":[511],"236":[513],"NNRTIs.":[515],"Associations":[516],"examined":[518,1294],"Spearman":[520],"correlations;":[521],"partial":[522],"correlations":[523,997,1148,1217,1296,1511],"used":[525,548],"adjust":[527],"Median":[533],"changes":[534,1298,1304,1314,1615],"sign":[539],"rank":[540],"test.":[541],"Baron":[543],"Kenny":[545],"method10":[546],"investigate":[550],"whether":[551],"effect":[553,964,1358,1564],"mediated":[561,972,1736],"through":[562,973],"At":[566,1026,1255,1506],"as":[569,1405,1540,1575,1752],"expected,":[570],"these":[576,1216,1597],"persons":[577,1401],"multidrug-resistant":[579],"tended":[581,771,1344],"correlate":[583,1346],"positively":[584,1188,1202],"activation:":[589],"TNF-\u03b1":[590,775,874,919,956,969,1039,1104,1205,1266],"(r":[591,598,605,630,641,653,675,695,701,727,875,886,909,924,1018,1040,1057,1192,1206,1212,1268,1287],"=":[592,599,602,606,609,631,634,642,645,654,657,676,679,696,702,711,728,731,749,782,791,803,816,827,839,876,879,887,890,910,913,925,928,959,991,1019,1041,1044,1058,1061,1091,1110,1144,1193,1196,1207,1213,1224,1269,1272,1288,1291],"0.77,":[593],"P":[594,601,608,633,644,656,678,730,748,765,781,790,802,815,826,838,878,889,912,927,1021,1043,1060,1074,1195,1271,1290],"<":[595,766],"0.001),":[596],"TNF-rII":[597,809,885,906,1070,1211],"0.53,":[600],"0.04),":[603,783,792],"IL-6":[604,784,1008,1072,1770],"0.50,":[607],"0.05).":[610],"did":[612,705,1218,1236,1320,1590,1626,1731],"not,":[613],"however,":[614],"observe":[615,1238,1322,1592,1628],"significant":[617,662,1147,1277,1324,1594,1630],"correlation":[618,664,901,917,1048,1240,1415,1595,1631],"CD38":[625,670],"CD8+":[628,639,673,821,833],"cells":[629,640,652,674,694,717,726,761,798,822,834],"0.18,":[632],"0.52),":[635],"CD38+/HLA-DR+":[636,648,690,722,794,830],"coexpression":[637,649,691,723,795,831],"\u22120.24,":[643],"0.40),":[646],"0.12,":[655,714],"0.68).":[658],"observed":[660,1050],"negative":[663,1097],"cell":[667,682,754,1639],"counts":[668,683],"\u22120.63,":[677],"0.02).":[680,1145],"seemed":[684,920,1033,1199,1359],"be":[686,922,1035,1201,1361,1425,1735],"negatively":[687,869,1036,1263,1347],"correlated":[688,720,870,1037,1068,1189,1203,1264],"\u22120.46)":[697],"\u22120.41)":[703],"reach":[707,1220],"statistical":[708,1221],"significance":[709,1222],"(P":[710,958,990,1090,1109,1143,1250],"0.10":[712],"respectively).":[715],"0.002,":[729,1092],"0.99).":[732],"As":[733,977,1077],"(median":[741,758,776,785,799,810,823,835,1118],"increase":[742,773,777,786,800,811,824,836],"0.2":[743],"log10":[744,779,788,813,896],"copies":[745],"per":[746,762],"milliliter,":[747],"0.006;":[750],"Table":[751],"1),":[752],"count":[755],"dropped":[756],"change":[759,994,1094],"\u221254":[760],"cubic":[763],"millimeter,":[764],"0.001);":[767],"0.3":[778],"pg/mL,":[780,789,814],"0.4":[787],"3%,":[801],"0.03),":[804,914],"less":[806,1122],"so":[807],"0.03":[812],"0.08),":[817],"CD38+":[818],"4%,":[825,837],"0.15),":[828],"0.35).TABLE":[840],"1:":[841],"Drug":[842],"Resistance":[843,1719],"Score,":[844],"RNA,":[846],"Cell":[848],"Count,":[849],"Markers":[851,1741],"Immune":[853],"Activation":[854],"Baseline":[856],"Changes":[858],"After":[859,892],"Treatment":[860],"InterruptionAt":[861],"baseline,":[862,1027,1183,1256,1355],"\u22120.49;":[877,1059],"0.05)":[880],"\u22120.51;":[888],"0.04).":[891],"adjusting":[893,1312],"level,":[899],"\u22120.61;":[911],"attenuated":[923],"\u22120.20;":[926],"0.53).":[929],"Further":[930],"regression":[931],"analyses":[932],"mediation":[937],"revealed":[938],"that,":[939],"0.12),":[960],"suggesting":[961],"declined":[985],"0.008,":[992],"median":[993,1093],"\u22121.0),":[995,1095],"no":[996,1106],"TNF-\u03b1,":[1005,1246],"TNF-rII,":[1006,1160,1247],"0.02\u20130.08;":[1020],">":[1022,1075,1251],"0.7":[1023],"all).":[1025,1254],"numbers":[1029,1259],"NRTI":[1031,1064,1084,1100],"\u22120.46,":[1042],"0.07).":[1045],"A":[1046],"0.09).":[1062],"(both":[1073],"0.90).":[1076],"frequency":[1079],"decreased":[1085,1138],"longer":[1107],"0.25).":[1111],"NNRTI":[1113,1137,1150],"1)":[1120],"prevalent":[1123],"NRTI.":[1131],"Frequencies":[1132],"No":[1146],"any":[1154,1239,1323,1593,1605],"inflammatory":[1157],"(TNF-\u03b1,":[1159],"IL-6)":[1162],"observed,":[1164],"either":[1165],"interruption.11":[1174],"Among":[1175],"8":[1176],"failing":[1178],"NNRTI-based":[1180],"regimen,":[1181],"IL6":[1191,1249],"0.85;":[1194],"0.008)":[1197,1273],"0.61)":[1208],"0.44),":[1214],"(p":[1223],"0.11":[1225],"0.27,":[1227],"respectively);":[1228],"0.5":[1252],"total":[1258],"\u22120.64;":[1270],"remained":[1275],"statistically":[1276],"magnitude":[1280,1487,1643,1682],"\u22120.59;":[1289],"0.03).":[1292],"markers,":[1308,1610],"without":[1311],"levels,":[1318,1366],"associations.":[1325],"In":[1326,1620],"investigation":[1328],"extensively":[1333],"individuals":[1335],"virus,":[1338],"independent":[1362],"consistent":[1367,1389],"results":[1370],"presented":[1371],"al.7":[1375,1410,1456],"This":[1376],"suggests":[1377],"described":[1406],"lack":[1412],"may":[1424,1483,1714],"small":[1429,1708],"sample":[1430,1709],"size":[1431,1710],"study":[1434,1441,1482,1498,1713],"characteristics":[1438],"population":[1442],"because":[1443],"examined,":[1450],"contrast":[1452,1621],"who":[1457,1825],"compared":[1458],"wild-type":[1466],"virus.":[1467],"Another":[1468],"possible":[1469,1520],"explanation":[1470],"difference":[1473],"our":[1475],"findings":[1476],"relate":[1484],"which":[1495,1765],"STI,":[1510],"much":[1513],"weaker":[1514],"baseline.":[1517],"It":[1518],"viral":[1522],"populations":[1523],"still":[1525],"dynamic":[1528],"phase":[1529],"time,":[1532],"yet":[1534],"steady":[1538],"state,":[1539],"supported":[1541],"heterogeneity":[1543],"rate":[1546],"reversion":[1548],"4-month":[1556,1749],"study.12":[1559],"assessed":[1562],"single":[1566],"point":[1567],"I54V":[1569],"V82A":[1571],"Natesampillai":[1576],"al13":[1578],"differential":[1580],"effects":[1581,1699],"caspase-induced":[1587],"apoptosis.":[1588],"2":[1598],"individually":[1600],"combination,":[1603],"examined.":[1619],"previous":[1623],"studies,":[1624],"markers.":[1641],"one":[1647],"several":[1649],"factors":[1650],"contribute":[1652],"level":[1655],"infection,":[1661],"subjects,":[1666],"persists":[1669],"controlled.":[1674],"Most":[1675],"studies":[1676,1691,1784],"demonstrating":[1677],"indices":[1686],"receiving":[1695],"therapies.":[1697],"incompletely":[1701],"suppressive":[1702],"therapy":[1704],"relatively":[1707],"confounded":[1716],"relationship.":[1718],"especially":[1726],"TNF-alpha;":[1728],"seem":[1733],"during":[1747,1772],"1":[1756],"month":[1757],"al,5":[1764],"showed":[1767],"follow-up":[1773],"mortality.":[1778],"These":[1779],"findings,":[1780],"together":[1781],"showing":[1785],"does":[1789],"improve":[1791],"virologic":[1792],"salvage":[1795],"regimens,9,14,15":[1796],"provides":[1797],"further":[1798],"argument":[1799],"against":[1800],"use":[1802],"strategies":[1806],"management":[1810],"individuals.":[1813],"ACKNOWLEDGMENTS":[1814],"authors":[1816],"thank":[1817],"investigators":[1822],"staff":[1824],"participated":[1826],"(clinicaltrials.gov":[1830],"NCT00011128).":[1831]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}